{"id":"NCT04091451","sponsor":"GlaxoSmithKline","briefTitle":"Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster","officialTitle":"A Phase III, Randomized, Observer-blind, Placebo Controlled, Multicenter Clinical Trial to Assess Herpes Zoster Recurrence and the Reactogenicity, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine (HZ/su) When Administered Intramuscularly on a 0 and 2 Month Schedule to Adults â‰¥50 Years of Age With a Prior Episode of Herpes Zoster","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-09-17","primaryCompletion":"2024-02-15","completion":"2024-02-15","firstPosted":"2019-09-16","resultsPosted":"2025-03-30","lastUpdate":"2025-03-30"},"enrollment":1430,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Herpes Zoster"],"interventions":[{"type":"BIOLOGICAL","name":"Herpes Zoster subunit (HZ/su) vaccine (GSK1437173A)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"HZ/su Group","type":"EXPERIMENTAL"},{"label":"Placebo Group","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study was to assess the safety and immunogenicity of GSK Biologicals' HZ/su vaccine when given on a two-dose schedule to adults aged 50 years and above who had a previous episode of Herpes Zoster (HZ).","primaryOutcome":{"measure":"Incidence Rate of Confirmed Herpes Zoster (HZ) Cases","timeFrame":"From 30 days post-second vaccination (Month 3) until study end (duration of approximately 2 years to 4 years and 5 months)","effectByArm":[{"arm":"HZ/su Group","deltaMin":0,"sd":null},{"arm":"Placebo Group","deltaMin":4.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":9,"exclusionCount":17},"locations":{"siteCount":44,"countries":["Estonia","Finland","Hong Kong","Mexico","Panama","Russia","Spain","United Kingdom"]},"refs":{"pmids":["37781954"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":56,"n":714},"commonTop":["Administration site pain","Fatigue","Headache","Malaise","Myalgia"]}}